SYNOX
Live / Registered — Registered (as of 27 Dec 2022)
What this means for you
Registered since 27 Dec 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90747052
- Registration number
- 6933250
- Mark type
- Stylized text
- Filed
- 01 Jun 2021
- Published for opposition
- 11 Oct 2022
- Registered
- 27 Dec 2022
- Attorney of record
- Patrice P. Jean
Goods and services
- Class 005 — Pharmaceuticals: Humanised antibody-based drugs for the treatment, diagnosis, detection and/or prevention of cancer and/or other oncological, autoimmune and inflammatory diseases; pharmaceutical products, namely, humanised antibody emactuzumab targeting the CSF1R (colony stimulating factor 1 receptor) in cancer for the treatment of cancer and inflammatory diseases; pharmaceutical products, namely, inhibitors of CSF1R and macrophage function for the treatment of cancer and/or other oncological, autoimmune and inflammatory diseases; pharmaceutical products, namely, inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of TGCT (tenosynovial giant cell tumour)/PVNS (pigmented villonodular synovitis); pharmaceutical compounds for the treatment, diagnosis, detection and/or prevention of cancer and/or other oncological, autoimmune and inflammatory diseases; pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer and/or other oncological, autoimmune and inflammatory diseases; biological preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer and/or other oncological, autoimmune and inflammatory diseases
Owner
- SynOx Therapeutics Limited, Dublin, IE
- SynOx Therapeutics Limited, Dublin, IE
- SynOx Therapeutics Limited, Dublin, IE
Prosecution history
- 27 Dec 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 Dec 2022 — REGISTERED-PRINCIPAL REGISTER
- 11 Oct 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Oct 2022 — PUBLISHED FOR OPPOSITION
- 21 Sept 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Sept 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Aug 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Aug 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Aug 2022 — ASSIGNED TO LIE
- 19 Jul 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 22 Feb 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 22 Feb 2022 — NON-FINAL ACTION E-MAILED
- 22 Feb 2022 — NON-FINAL ACTION WRITTEN
- 15 Feb 2022 — ASSIGNED TO EXAMINER
- 25 Aug 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED